Takeda invests in continuous processing; Actavis recalls metformin;

> Takeda Ventures is investing €3 million ($3.3 million) in Belgium-based Univercells and will tailor Univercells' continuous integrated manufacturing methods for Takeda's vaccines production processes. Release

> India's National Dairy Development Board has started manufacturing from a new $38.6 million animal and human vaccine manufacturing plant near Hyderabad. Story

> Pharmaceutical production increased 29.2% in Singapore for the 12 months ending Sept. 30, coming off a low base the year before. Story

> Actavis is recalling more than 13,280 bottles of metformin after a lot failed dissolution testing. Recall

> Canada's Apotex is recalling 28,802 bottles of Bromfenac Ophthalmic Solution after lots failed preservative effectiveness testing. Recall

Suggested Articles

President Trump is set to issue an executive order centering on U.S. production for drugs and medical supplies, and pharma is sure to push back. 

The lawmakers question Kodak's fitness for such a major pharma manufacturing deal, as well as suspicious stock transactions by company leadership.

AZ's China COVID-19 vaccine deal comes after supply agreements with the U.S., the U.K., EU and Brazil, as well as licensing pacts in India and Japan.